Table 4.

Probabilistic base case results

	Cost	(95% confidence interval)	Incremental cost (95% confidence interval)
Maintain Treatment with Reference Infliximab	$96,385	($83,213 to $109,976)	−$46,194 (−$42,420 to −$50,455)
Switch to Maintenance Treatment with Biosimilar Infliximab	$50,191	($40,792 to $59,521)
	Effectiveness per patient	(95% confidence interval)	Incremental effect (95% confidence interval)
Maintain Treatment with Reference Infliximab	3.19	(2.47 to 3.83)	−0.13 (−0.16 to −0.07)
Switch to Maintenance Treatment with Biosimilar Infliximab	3.06	(2.31 to 3.76)

All costs in 2017 Canadian dollars.